| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside binding | 1.69e-05 | 3 | 48 | 2 | GO:0032549 | |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 5.63e-05 | 5 | 48 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | nucleoside binding | 3.07e-04 | 11 | 48 | 2 | GO:0001882 | |
| GeneOntologyMolecularFunction | Arp2/3 complex binding | 6.65e-04 | 16 | 48 | 2 | GO:0071933 | |
| GeneOntologyBiologicalProcess | actin filament debranching | 5.53e-06 | 2 | 49 | 2 | GO:0071846 | |
| Domain | GMF | 6.20e-06 | 2 | 47 | 2 | IPR011171 | |
| Domain | - | 1.86e-05 | 3 | 47 | 2 | 2.40.270.10 | |
| Domain | DNA-dir_RNA_pol_su2 | 1.86e-05 | 3 | 47 | 2 | IPR015712 | |
| Domain | RNA_pol_RPB2_OB-fold | 1.86e-05 | 3 | 47 | 2 | IPR014724 | |
| Domain | RNA_pol_bsu_CS | 1.86e-05 | 3 | 47 | 2 | IPR007121 | |
| Domain | DNA-dir_RNA_pol_su2_6 | 1.86e-05 | 3 | 47 | 2 | IPR007120 | |
| Domain | RNA_pol_Rpb2_6 | 1.86e-05 | 3 | 47 | 2 | PF00562 | |
| Domain | RNA_pol_Rpb2_7 | 1.86e-05 | 3 | 47 | 2 | PF04560 | |
| Domain | RNA_pol_Rpb2_2 | 1.86e-05 | 3 | 47 | 2 | PF04561 | |
| Domain | RNA_pol_Rpb2_5 | 1.86e-05 | 3 | 47 | 2 | PF04567 | |
| Domain | RNA_pol_Rpb2_1 | 1.86e-05 | 3 | 47 | 2 | PF04563 | |
| Domain | RNA_pol_Rpb2_3 | 1.86e-05 | 3 | 47 | 2 | PF04565 | |
| Domain | RNA_pol_Rpb2_5 | 1.86e-05 | 3 | 47 | 2 | IPR007647 | |
| Domain | RNA_pol_Rpb2_3 | 1.86e-05 | 3 | 47 | 2 | IPR007645 | |
| Domain | RNA_pol_bsu_protrusion | 1.86e-05 | 3 | 47 | 2 | IPR007644 | |
| Domain | RNA_pol_Rpb2_2 | 1.86e-05 | 3 | 47 | 2 | IPR007642 | |
| Domain | RNA_pol_Rpb2_7 | 1.86e-05 | 3 | 47 | 2 | IPR007641 | |
| Domain | - | 1.86e-05 | 3 | 47 | 2 | 2.40.50.150 | |
| Domain | RNA_POL_BETA | 1.86e-05 | 3 | 47 | 2 | PS01166 | |
| Domain | - | 1.86e-05 | 3 | 47 | 2 | 3.90.1110.10 | |
| Domain | Spectrin_repeat | 5.21e-05 | 29 | 47 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 7.04e-05 | 32 | 47 | 3 | IPR018159 | |
| Domain | SPEC | 7.04e-05 | 32 | 47 | 3 | SM00150 | |
| Domain | ADF | 2.75e-04 | 10 | 47 | 2 | SM00102 | |
| Domain | Cofilin_ADF | 2.75e-04 | 10 | 47 | 2 | PF00241 | |
| Domain | ADF_H | 2.75e-04 | 10 | 47 | 2 | PS51263 | |
| Domain | ADF-H | 2.75e-04 | 10 | 47 | 2 | IPR002108 | |
| Domain | Actinin_actin-bd_CS | 1.52e-03 | 23 | 47 | 2 | IPR001589 | |
| Domain | NACHT | 1.52e-03 | 23 | 47 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 1.52e-03 | 23 | 47 | 2 | IPR007111 | |
| Domain | Spectrin | 1.52e-03 | 23 | 47 | 2 | PF00435 | |
| Domain | ACTININ_2 | 1.52e-03 | 23 | 47 | 2 | PS00020 | |
| Domain | ACTININ_1 | 1.52e-03 | 23 | 47 | 2 | PS00019 | |
| Domain | ADF-H/Gelsolin-like_dom | 1.65e-03 | 24 | 47 | 2 | IPR029006 | |
| Domain | - | 1.65e-03 | 24 | 47 | 2 | 3.40.20.10 | |
| Domain | Arm | 2.75e-03 | 31 | 47 | 2 | PF00514 | |
| Domain | BROMODOMAIN_1 | 3.90e-03 | 37 | 47 | 2 | PS00633 | |
| Domain | EGF | 3.92e-03 | 126 | 47 | 3 | PF00008 | |
| Domain | Bromodomain | 4.11e-03 | 38 | 47 | 2 | PF00439 | |
| Domain | ARM_REPEAT | 4.55e-03 | 40 | 47 | 2 | PS50176 | |
| Domain | ARM | 4.55e-03 | 40 | 47 | 2 | SM00185 | |
| Domain | BROMODOMAIN_2 | 4.77e-03 | 41 | 47 | 2 | PS50014 | |
| Domain | BROMO | 5.01e-03 | 42 | 47 | 2 | SM00297 | |
| Domain | Bromodomain | 5.01e-03 | 42 | 47 | 2 | IPR001487 | |
| Domain | - | 5.01e-03 | 42 | 47 | 2 | 1.20.920.10 | |
| Domain | Armadillo | 6.23e-03 | 47 | 47 | 2 | IPR000225 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.81e-06 | 10 | 36 | 3 | MM14956 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 2.49e-06 | 11 | 36 | 3 | M9990 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 5.17e-05 | 161 | 36 | 5 | M39770 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 1.12e-04 | 37 | 36 | 3 | MM14488 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 1.21e-04 | 38 | 36 | 3 | M495 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 2.60e-04 | 49 | 36 | 3 | MM15448 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 3.10e-04 | 52 | 36 | 3 | M2341 | |
| Pubmed | Antagonistic Regulation of Intercellular Cohesion by Plakophilins 1 and 3. | 5.24e-08 | 6 | 49 | 3 | 27375112 | |
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 17535849 | ||
| Pubmed | 4.30e-07 | 11 | 49 | 3 | 11790773 | ||
| Pubmed | Excess LINC complexes impair brain morphogenesis in a mouse model of recessive TOR1A disease. | 5.73e-07 | 12 | 49 | 3 | 29868845 | |
| Pubmed | Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. | 1.18e-06 | 15 | 49 | 3 | 9847250 | |
| Pubmed | p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome. | 1.18e-06 | 15 | 49 | 3 | 23108156 | |
| Pubmed | Desmocollin 3 is required for pre-implantation development of the mouse embryo. | 1.45e-06 | 16 | 49 | 3 | 16418220 | |
| Pubmed | Coronary veins determine the pattern of sympathetic innervation in the developing heart. | 1.45e-06 | 16 | 49 | 3 | 23462468 | |
| Pubmed | 1.45e-06 | 16 | 49 | 3 | 30689641 | ||
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 11781569 | ||
| Pubmed | FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. | 1.94e-06 | 2 | 49 | 2 | 38589650 | |
| Pubmed | Novel truncating mutations in PKP1 and DSP cause similar skin phenotypes in two Brazilian families. | 1.94e-06 | 2 | 49 | 2 | 19016709 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 37625794 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 20517925 | ||
| Pubmed | Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma. | 1.94e-06 | 2 | 49 | 2 | 27385092 | |
| Pubmed | Nesprins are mechanotransducers that discriminate epithelial-mesenchymal transition programs. | 1.94e-06 | 2 | 49 | 2 | 32790861 | |
| Pubmed | Isolation of novel human cDNA (hGMF-gamma) homologous to Glia Maturation Factor-beta gene. | 1.94e-06 | 2 | 49 | 2 | 9545571 | |
| Pubmed | beta-Catenin and plakoglobin N- and C-tails determine ligand specificity. | 1.94e-06 | 2 | 49 | 2 | 15381698 | |
| Pubmed | N-terminal nesprin-2 variants regulate β-catenin signalling. | 1.94e-06 | 2 | 49 | 2 | 27321956 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 19661437 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 20811503 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11435704 | ||
| Pubmed | Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. | 2.95e-06 | 20 | 49 | 3 | 26033091 | |
| Pubmed | Phorbol ester stimulates rapid intracellular phosphorylation of glia maturation factor. | 5.83e-06 | 3 | 49 | 2 | 7598724 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27890434 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 30425057 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 8798479 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 36179694 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21215703 | ||
| Pubmed | Low-Dose Tamoxifen Induces Significant Bone Formation in Mice. | 5.83e-06 | 3 | 49 | 2 | 33778320 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16823493 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 29566281 | ||
| Pubmed | Plakoglobin is required for effective intermediate filament anchorage to desmosomes. | 5.83e-06 | 3 | 49 | 2 | 18496566 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27033150 | ||
| Pubmed | lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal. | 5.83e-06 | 3 | 49 | 2 | 27239797 | |
| Pubmed | 1.04e-05 | 30 | 49 | 3 | 34905516 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 17428233 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8858175 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 36877334 | ||
| Pubmed | Spatiotemporal regulation of liver development by the Wnt/β-catenin pathway. | 1.16e-05 | 4 | 49 | 2 | 29426940 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 27092879 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 23444369 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 24238339 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8639570 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 29445149 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 24608043 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 17593084 | ||
| Pubmed | Genome-wide occupancy links Hoxa2 to Wnt-β-catenin signaling in mouse embryonic development. | 1.16e-05 | 4 | 49 | 2 | 22223247 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8950514 | ||
| Pubmed | Defining the interactions between intermediate filaments and desmosomes. | 1.94e-05 | 5 | 49 | 2 | 9606214 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 17502350 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 27015268 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 11500511 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 19136012 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 25373781 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.43e-05 | 857 | 49 | 8 | 25609649 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 31066677 | ||
| Pubmed | Katanin p80 regulates human cortical development by limiting centriole and cilia number. | 2.91e-05 | 6 | 49 | 2 | 25521379 | |
| Pubmed | PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation. | 2.91e-05 | 6 | 49 | 2 | 24055345 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 15198985 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 28131747 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 12975353 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 19001373 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 30932813 | ||
| Pubmed | Phosphorylation of Pkp1 by RIPK4 regulates epidermal differentiation and skin tumorigenesis. | 4.07e-05 | 7 | 49 | 2 | 28507225 | |
| Pubmed | Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation. | 4.07e-05 | 7 | 49 | 2 | 24469040 | |
| Pubmed | Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. | 4.07e-05 | 7 | 49 | 2 | 15479741 | |
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 37365500 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 23972596 | ||
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 10801826 | ||
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 29223978 | ||
| Pubmed | Wnt signaling has opposing roles in the developing and the adult brain that are modulated by Hipk1. | 5.42e-05 | 8 | 49 | 2 | 22095214 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 33497368 | ||
| Pubmed | The cell adhesion molecule nectin-1 is critical for normal enamel formation in mice. | 6.96e-05 | 9 | 49 | 2 | 18703497 | |
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 31130994 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 24832538 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 24953933 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 39052671 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 23180754 | ||
| Pubmed | Altered cholesterol biosynthesis causes precocious neurogenesis in the developing mouse forebrain. | 6.96e-05 | 9 | 49 | 2 | 26921468 | |
| Pubmed | Alix is required during development for normal growth of the mouse brain. | 6.96e-05 | 9 | 49 | 2 | 28322231 | |
| Pubmed | A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. | 6.96e-05 | 9 | 49 | 2 | 9707618 | |
| Pubmed | 7.29e-05 | 57 | 49 | 3 | 21122108 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 10852826 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 32186707 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 12724416 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 20103535 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 17706960 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 20215343 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 32822074 | ||
| Pubmed | USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. | 8.69e-05 | 10 | 49 | 2 | 36653359 | |
| Pubmed | Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis. | 8.69e-05 | 10 | 49 | 2 | 17532316 | |
| Pubmed | Norrie disease protein is essential for cochlear hair cell maturation. | 8.69e-05 | 10 | 49 | 2 | 34544869 | |
| Pubmed | 9.83e-05 | 63 | 49 | 3 | 34351428 | ||
| Pubmed | Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells. | 1.06e-04 | 11 | 49 | 2 | 24860427 | |
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 37553426 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 33127892 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 20084116 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 19144645 | ||
| Pubmed | FASN-dependent de novo lipogenesis is required for brain development. | 1.06e-04 | 11 | 49 | 2 | 34996870 | |
| GeneFamily | NLR family | 1.00e-03 | 25 | 34 | 2 | 666 | |
| GeneFamily | RNA polymerase subunits | 1.35e-03 | 29 | 34 | 2 | 726 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.95e-03 | 43 | 34 | 2 | 409 | |
| Coexpression | PGF_UP.V1_UP | 2.27e-05 | 190 | 47 | 5 | M2674 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN | 2.45e-05 | 193 | 47 | 5 | M4284 | |
| Coexpression | GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP | 2.71e-05 | 197 | 47 | 5 | M3555 | |
| Coexpression | TRAVAGLINI_LUNG_PERICYTE_CELL | 5.24e-05 | 114 | 47 | 4 | M41678 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-08 | 191 | 48 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 174 | 48 | 5 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 174 | 48 | 5 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.48e-06 | 181 | 48 | 5 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.79e-06 | 188 | 48 | 5 | ee8ff134a639deca2bb3027c4d3291f48c12d171 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 191 | 48 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 191 | 48 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 2.03e-06 | 193 | 48 | 5 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-06 | 196 | 48 | 5 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.30e-06 | 198 | 48 | 5 | 531b0f88c95f813e3914c96749f591e80ca321d0 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.42e-06 | 200 | 48 | 5 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.42e-06 | 200 | 48 | 5 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.11e-05 | 151 | 48 | 4 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.11e-05 | 151 | 48 | 4 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 2.46e-05 | 157 | 48 | 4 | af6eb2214340847bbab7cb209ea27cdc83b62a27 | |
| ToppCell | 18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class | 2.53e-05 | 158 | 48 | 4 | 183f445967e09e871c93d8e94781ed9fec894169 | |
| ToppCell | Club-club-1|World / Class top | 2.72e-05 | 54 | 48 | 3 | 48f80b20b1c4995a0f7084d31666781dce4009a9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 167 | 48 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.14e-05 | 167 | 48 | 4 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 3.76e-05 | 175 | 48 | 4 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.29e-05 | 181 | 48 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.39e-05 | 182 | 48 | 4 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.48e-05 | 183 | 48 | 4 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 4.67e-05 | 185 | 48 | 4 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-05 | 186 | 48 | 4 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-05 | 186 | 48 | 4 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.77e-05 | 186 | 48 | 4 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-05 | 187 | 48 | 4 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-05 | 187 | 48 | 4 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-05 | 187 | 48 | 4 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 4.87e-05 | 187 | 48 | 4 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.87e-05 | 187 | 48 | 4 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 4.87e-05 | 187 | 48 | 4 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 4.98e-05 | 188 | 48 | 4 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-05 | 189 | 48 | 4 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 5.18e-05 | 190 | 48 | 4 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.18e-05 | 190 | 48 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.18e-05 | 190 | 48 | 4 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-05 | 190 | 48 | 4 | 600b9674197f743dea1d19d3df0fc993b6e6aa25 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 5.29e-05 | 191 | 48 | 4 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.40e-05 | 192 | 48 | 4 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | E15.5-Endothelial|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.40e-05 | 192 | 48 | 4 | 88cc7f14d031a0613d032eb01c93e88c72d3938f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.40e-05 | 192 | 48 | 4 | 3b0a52e4e77ae4539a034dcb419773b8e2aa5d51 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.51e-05 | 193 | 48 | 4 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.51e-05 | 193 | 48 | 4 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 5.51e-05 | 193 | 48 | 4 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 5.51e-05 | 193 | 48 | 4 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.51e-05 | 193 | 48 | 4 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.51e-05 | 193 | 48 | 4 | ff6e6b825d6c88148216c601580be3c28851ab5c | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 5.51e-05 | 193 | 48 | 4 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.51e-05 | 193 | 48 | 4 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 5.62e-05 | 194 | 48 | 4 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | Endothelial-A-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.62e-05 | 194 | 48 | 4 | e656ac5539e59e321b46706cb8cc423b2c3358a0 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 5.62e-05 | 194 | 48 | 4 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 5.62e-05 | 194 | 48 | 4 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 194 | 48 | 4 | 592e8c4b73ba424a52305ac411ea9c0a2dc44467 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 5.62e-05 | 194 | 48 | 4 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | Endothelial|World / shred by cell class for bronchial biopsy | 5.73e-05 | 195 | 48 | 4 | f0e46e859f7a9bdead3203889f7e20fa21f76ff0 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.85e-05 | 196 | 48 | 4 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.85e-05 | 196 | 48 | 4 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 5.85e-05 | 196 | 48 | 4 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 5.85e-05 | 196 | 48 | 4 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | 5.85e-05 | 196 | 48 | 4 | 0ce3ed27d2b9276390952652c17a8d6de13add36 | |
| ToppCell | tumor_Lung-Endothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 5.97e-05 | 197 | 48 | 4 | 6870b311c54a73723768276a58456620f5217d43 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 5.97e-05 | 197 | 48 | 4 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.97e-05 | 197 | 48 | 4 | 80ffafa9473f4ee7a3a792d11b5541e1c984c9f0 | |
| ToppCell | (4)_Blood_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.97e-05 | 197 | 48 | 4 | 1b82979a41ef46c814c82527a585900586d71260 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.97e-05 | 197 | 48 | 4 | 9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d | |
| ToppCell | (4)_Endothelial_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.97e-05 | 197 | 48 | 4 | dd9abb43c23e7698433e455eacbf5b23b0a756c2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.97e-05 | 197 | 48 | 4 | f3dfc22ff63e6173451a0917c5aedcde793fd170 | |
| ToppCell | COVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 5.97e-05 | 197 | 48 | 4 | 39ee4b93625c994813044d8dd8854fba2bd99940 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 6.20e-05 | 199 | 48 | 4 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.20e-05 | 199 | 48 | 4 | b15304d3d3f6c254969b54a61bee3d9f368840b2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-05 | 199 | 48 | 4 | 5d976d57872a8a25a11fe8cd53b01aa21a1a519a | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.20e-05 | 199 | 48 | 4 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.20e-05 | 199 | 48 | 4 | c5c12c8288fe868322bae9d691b91fee953ceb3e | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-05 | 199 | 48 | 4 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | 2d962c9d63e9e5f1a06870e383609672e7b1738c | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Capillary|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | 6c0498a5868891e8e22c03469d00669b20249b1a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Biopsy_Other_PF-Endothelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | f9916134486fb1dac55f5e7e8deb35e7a3b85770 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | 2989325b0e78ab42f362cfb59e34a4fce7f8e869 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.33e-05 | 200 | 48 | 4 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | abcbd5a156aa4fd51d284441388975c81c0b88ae | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.33e-05 | 200 | 48 | 4 | 7020045b933cb104fb99b79524cb0d4734b8636d | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.33e-05 | 200 | 48 | 4 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Biopsy_Other_PF-Endothelial-Endothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | 40d57a383c79d3365e033d08efd9371f0bc5bf55 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.33e-05 | 200 | 48 | 4 | d9d0ffa18e5b4647966e19ad9830cbba6120677e | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.33e-05 | 200 | 48 | 4 | e9913511a129bb3cee85e7ebf565b951dab91542 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.33e-05 | 200 | 48 | 4 | e9d5ba140cabae11c437012d519b85f5412dcc94 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.33e-05 | 200 | 48 | 4 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.33e-05 | 200 | 48 | 4 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| Disease | Persistent Fetal Circulation Syndrome | 2.27e-06 | 2 | 45 | 2 | C0031190 | |
| Disease | Ectodermal dysplasia/ skin fragility syndrome | 2.27e-06 | 2 | 45 | 2 | C1858302 | |
| Disease | persistent fetal circulation syndrome (is_implicated_in) | 6.82e-06 | 3 | 45 | 2 | DOID:13042 (is_implicated_in) | |
| Disease | Exudative vitreoretinopathy 1 | 1.36e-05 | 4 | 45 | 2 | C1851402 | |
| Disease | exudative vitreoretinopathy (implicated_via_orthology) | 6.33e-05 | 8 | 45 | 2 | DOID:0050535 (implicated_via_orthology) | |
| Disease | hepatitis B (is_marker_for) | 4.69e-04 | 21 | 45 | 2 | DOID:2043 (is_marker_for) | |
| Disease | myeloid white cell count | 5.04e-04 | 937 | 45 | 7 | EFO_0007988 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 5.15e-04 | 22 | 45 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 5.27e-04 | 103 | 45 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | ergothioneine measurement | 7.22e-04 | 26 | 45 | 2 | EFO_0021163 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 8.42e-04 | 121 | 45 | 3 | EFO_0008595, EFO_0020943 | |
| Disease | level of Sphingomyelin (d38:1) in blood serum | 9.63e-04 | 30 | 45 | 2 | OBA_2045180 | |
| Disease | neutrophil count | 1.04e-03 | 1382 | 45 | 8 | EFO_0004833 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.14e-03 | 301 | 45 | 4 | DOID:684 (is_marker_for) | |
| Disease | nephroblastoma (is_marker_for) | 1.24e-03 | 34 | 45 | 2 | DOID:2154 (is_marker_for) | |
| Disease | Neoplastic Cell Transformation | 1.26e-03 | 139 | 45 | 3 | C0007621 | |
| Disease | triacylglycerol 58:8 measurement | 1.31e-03 | 35 | 45 | 2 | EFO_0010442 | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 1.39e-03 | 36 | 45 | 2 | DOID:3907 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAKMQKGYNSQMRSE | 46 | Q13075 | |
| QPGAQRMYKQSMAQR | 41 | O00555 | |
| TCGKADNNMQGNKMY | 336 | O95936 | |
| TPEQYKMCMQSKAMN | 486 | Q8TDX6 | |
| CALKRMYVNNMPDLN | 76 | Q9NSY1 | |
| MNKMPAGEQECEYNK | 1 | Q8N7E2 | |
| NDMKTMFRNCRKYNG | 501 | Q9BXF3 | |
| VGKPLYQSMNCKPMQ | 631 | Q6P3S6 | |
| NYKNKMMVCQVGGIE | 431 | P35222 | |
| PSNSPGNKKMMIYCN | 151 | A0A1B0GTS1 | |
| GNKKMMIYCNSNFQR | 156 | A0A1B0GTS1 | |
| CKPEQQMMYAGSKNR | 96 | O60234 | |
| VNPNCYAKVMMVNGD | 691 | Q15910 | |
| KCPKKPSYHGYNQMM | 596 | Q14766 | |
| METMKSKANCAQNPN | 1 | Q6B0I6 | |
| QNNFSPKGMMKLCSA | 1131 | P59047 | |
| PSNSPGNKKMMIYCN | 151 | A0A1B0GWH4 | |
| GNKKMMIYCNSNFQR | 156 | A0A1B0GWH4 | |
| GQYQIKMKGNMSLIC | 391 | Q8N414 | |
| TRQCVYMMKQPQGEQ | 731 | O60494 | |
| SMCQNLGYNVTKMPN | 51 | Q9ULV1 | |
| AKTYKMSMANRGQNQ | 306 | P31327 | |
| KNIANMCRGIPTYMA | 136 | Q9NS71 | |
| MKYQQKAAGMSPEQV | 181 | Q8TDQ1 | |
| REMRQMGQPCDAYQK | 126 | P15924 | |
| NSQMFQGRPCKNMYP | 711 | O75976 | |
| LKYQPMMQTIGQKYC | 66 | Q8N1E2 | |
| MKPINKCIGRNMTYF | 331 | Q6NUT3 | |
| SYIMKQCVFMENPNK | 941 | Q86YS7 | |
| GYPALMDCMNKLKNN | 131 | Q9BPW8 | |
| NKSDKMMNNNYDCPL | 516 | Q13835 | |
| RKCQALKPMYSMMNG | 146 | Q12946 | |
| CKPEQQMMYAGSKNK | 96 | P60983 | |
| GECQNINKQYMMVKS | 551 | Q8WXH0 | |
| GMQALYKVKSCSMAP | 356 | Q9BQS7 | |
| MKNKMEIQGNPKYRA | 416 | Q13203 | |
| SKMRANNQKVYMPRE | 371 | Q01082 | |
| MPYKCSSCSQQFMQK | 376 | P10074 | |
| KSQLMCQQMYMGEKP | 261 | Q14587 | |
| QGEKLYKMMCRQGNL | 381 | Q70Z35 | |
| PRNTYQCAMGKQAMG | 681 | Q9NW08 | |
| LSRAKKGMYCIGNMQ | 1221 | Q9P2E3 | |
| QLNKMPNCMAVSQDY | 101 | Q6P2C0 | |
| DKRKNMYSGGENVQM | 401 | Q9Y6R1 | |
| QMDNMLVQTNKPYKC | 436 | Q8N680 | |
| QSPRNMYQCQMGKQT | 681 | Q9H9Y6 | |
| MRASPGLSMYDQKKC | 1036 | O15016 | |
| NTEEMKMKNPGRYQI | 116 | A0A087WXS9 | |
| MYKMNICNKPSNKTA | 1 | Q8WTX9 | |
| GLCGNYDKNRKNDMM | 2466 | Q9Y493 | |
| KCMYAPKPKVMQTCN | 461 | P82987 |